Allogeneic Transplant and Gene Therapy in Sickle Cell Disease

Markus Y. Mapara, MD, PhD, of Columbia University Irving Cancer Center, discusses the use of allogeneic transplant and gene therapy for patients with sickle cell disease.

Markus Y. Mapara, MD, PhD, of Columbia University Irving Cancer Center, discusses the use of allogeneic transplant and gene therapy for patients with sickle cell disease.

Related Content:

Keynote ConferenceColumbia University Herbert Irving Comprehensive Cancer CenterHematologic Oncology
Dr Michot on the Importance of the OLYMPIA-3 Study of Odronextamab Plus Chemo in DLBCL
“Smart” Strategy of Up-front Targeted Therapy Reduces Need for Chemo in LBCL
Revumenib Plus Decitabine/Cedazuridine and Venetoclax Proves Efficacious in Newly Diagnosed AML